PULMONX CORPORATION
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-54.0M | $-56.4M | $-60.8M | $-58.9M | $-48.7M | $-32.2M | $-20.7M | $-18.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $1.1M | $1.1M | $1.4M | $1.4M | $700.0K | $300.0K | $200.0K | $100.0K |
| Amortization | — | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Stock-Based Compensation | $21.2M | $23.0M | $22.1M | $16.4M | $10.5M | $3.2M | $364.0K | $366.0K |
| Net Cash from Operating Activities | $-32.4M | $-31.5M | $-37.6M | $-45.1M | $-41.4M | $-30.6M | $-20.8M | $-18.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $452.0K | $1.4M | $807.0K | $1.3M | $3.7M | $911.0K | $720.0K | $316.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $30.5M | $17.5M | $-2.0M | $-4.2M | $-46.3M | $12.7M | $-14.2M | $200.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | $0 | $27.0K | $26.0K | $21.0K | $12.0K | $0 |
| Net Cash from Financing Activities | $833.0K | $1.4M | $21.4M | $2.4M | $4.5M | $234.8M | $45.6M | $12.1M |
| Net Change in Cash | $-1.2M | $-12.6M | $-18.2M | $-46.7M | $-83.1M | $217.0M | $10.6M | $-5.9M |
| Free Cash Flow | $-32.8M | $-33.0M | $-38.4M | $-46.4M | $-45.1M | $-31.5M | $-21.5M | $-18.7M |